201 related articles for article (PubMed ID: 32079288)
1. Quality Assessment of Virus-Like Particles at Single Particle Level: A Comparative Study.
González-Domínguez I; Puente-Massaguer E; Cervera L; Gòdia F
Viruses; 2020 Feb; 12(2):. PubMed ID: 32079288
[TBL] [Abstract][Full Text] [Related]
2. Application of advanced quantification techniques in nanoparticle-based vaccine development with the Sf9 cell baculovirus expression system.
Puente-Massaguer E; Lecina M; Gòdia F
Vaccine; 2020 Feb; 38(7):1849-1859. PubMed ID: 31911032
[TBL] [Abstract][Full Text] [Related]
3. Coupling Microscopy and Flow Cytometry for a Comprehensive Characterization of Nanoparticle Production in Insect Cells.
Puente-Massaguer E; Saccardo P; Ferrer-Miralles N; Lecina M; Gòdia F
Cytometry A; 2020 Sep; 97(9):921-932. PubMed ID: 32515126
[TBL] [Abstract][Full Text] [Related]
4. Integrating nanoparticle quantification and statistical design of experiments for efficient HIV-1 virus-like particle production in High Five cells.
Puente-Massaguer E; Lecina M; Gòdia F
Appl Microbiol Biotechnol; 2020 Feb; 104(4):1569-1582. PubMed ID: 31907573
[TBL] [Abstract][Full Text] [Related]
5. Development of a non-viral platform for rapid virus-like particle production in Sf9 cells.
Puente-Massaguer E; Gòdia F; Lecina M
J Biotechnol; 2020 Oct; 322():43-53. PubMed ID: 32673687
[TBL] [Abstract][Full Text] [Related]
6. Quantification of the HIV-1 virus-like particle production process by super-resolution imaging: From VLP budding to nanoparticle analysis.
González-Domínguez I; Puente-Massaguer E; Cervera L; Gòdia F
Biotechnol Bioeng; 2020 Jul; 117(7):1929-1945. PubMed ID: 32242921
[TBL] [Abstract][Full Text] [Related]
7. Critical assessment of influenza VLP production in Sf9 and HEK293 expression systems.
Thompson CM; Petiot E; Mullick A; Aucoin MG; Henry O; Kamen AA
BMC Biotechnol; 2015 May; 15():31. PubMed ID: 25981500
[TBL] [Abstract][Full Text] [Related]
8. A 3.0-Angstrom Resolution Cryo-Electron Microscopy Structure and Antigenic Sites of Coxsackievirus A6-Like Particles.
Chen J; Zhang C; Zhou Y; Zhang X; Shen C; Ye X; Jiang W; Huang Z; Cong Y
J Virol; 2018 Jan; 92(2):. PubMed ID: 29093091
[TBL] [Abstract][Full Text] [Related]
9. Morphological characterization of a plant-made virus-like particle vaccine bearing influenza virus hemagglutinins by electron microscopy.
Lindsay BJ; Bonar MM; Costas-Cancelas IN; Hunt K; Makarkov AI; Chierzi S; Krawczyk CM; Landry N; Ward BJ; Rouiller I
Vaccine; 2018 Apr; 36(16):2147-2154. PubMed ID: 29550194
[TBL] [Abstract][Full Text] [Related]
10. Perturbation of Human T-Cell Leukemia Virus Type 1 Particle Morphology by Differential Gag Co-Packaging.
Maldonado JO; Angert I; Cao S; Berk S; Zhang W; Mueller JD; Mansky LM
Viruses; 2017 Jul; 9(7):. PubMed ID: 28753950
[TBL] [Abstract][Full Text] [Related]
11. Bioanalytics for Influenza Virus-Like Particle Characterization and Process Monitoring.
Carvalho SB; Silva RJS; Sousa MFQ; Peixoto C; Roldão A; Carrondo MJT; Alves PM
Front Bioeng Biotechnol; 2022; 10():805176. PubMed ID: 35252128
[TBL] [Abstract][Full Text] [Related]
12. Biophysical analysis of HTLV-1 particles reveals novel insights into particle morphology and Gag stochiometry.
Grigsby IF; Zhang W; Johnson JL; Fogarty KH; Chen Y; Rawson JM; Crosby AJ; Mueller JD; Mansky LM
Retrovirology; 2010 Sep; 7():75. PubMed ID: 20854688
[TBL] [Abstract][Full Text] [Related]
13. The Respiratory Syncytial Virus Phosphoprotein, Matrix Protein, and Fusion Protein Carboxy-Terminal Domain Drive Efficient Filamentous Virus-Like Particle Formation.
Meshram CD; Baviskar PS; Ognibene CM; Oomens AGP
J Virol; 2016 Dec; 90(23):10612-10628. PubMed ID: 27654298
[TBL] [Abstract][Full Text] [Related]
14. Identification of HIV-1-Based Virus-like Particles by Multifrequency Atomic Force Microscopy.
González-Domínguez I; Gutiérrez-Granados S; Cervera L; Gòdia F; Domingo N
Biophys J; 2016 Sep; 111(6):1173-1179. PubMed ID: 27653476
[TBL] [Abstract][Full Text] [Related]
15. Distinct Particle Morphologies Revealed through Comparative Parallel Analyses of Retrovirus-Like Particles.
Martin JL; Cao S; Maldonado JO; Zhang W; Mansky LM
J Virol; 2016 Sep; 90(18):8074-84. PubMed ID: 27356903
[TBL] [Abstract][Full Text] [Related]
16. Cryo-electron microscopy study of insect cell-expressed enterovirus 71 and coxsackievirus a16 virus-like particles provides a structural basis for vaccine development.
Gong M; Zhu H; Zhou J; Yang C; Feng J; Huang X; Ji G; Xu H; Zhu P
J Virol; 2014 Jun; 88(11):6444-52. PubMed ID: 24672036
[TBL] [Abstract][Full Text] [Related]
17. Virus-like particle of Macrobrachium rosenbergii nodavirus produced in Spodoptera frugiperda (Sf9) cells is distinctive from that produced in Escherichia coli.
Kueh CL; Yong CY; Masoomi Dezfooli S; Bhassu S; Tan SG; Tan WS
Biotechnol Prog; 2017 Mar; 33(2):549-557. PubMed ID: 27860432
[TBL] [Abstract][Full Text] [Related]
18. Toolbox for non-intrusive structural and functional analysis of recombinant VLP based vaccines: a case study with hepatitis B vaccine.
Mulder AM; Carragher B; Towne V; Meng Y; Wang Y; Dieter L; Potter CS; Washabaugh MW; Sitrin RD; Zhao Q
PLoS One; 2012; 7(4):e33235. PubMed ID: 22493667
[TBL] [Abstract][Full Text] [Related]
19. Characterization of influenza H1N1 Gag virus-like particles and extracellular vesicles co-produced in HEK-293SF.
Venereo-Sánchez A; Fulton K; Koczka K; Twine S; Chahal P; Ansorge S; Gilbert R; Henry O; Kamen A
Vaccine; 2019 Nov; 37(47):7100-7107. PubMed ID: 31358407
[TBL] [Abstract][Full Text] [Related]
20. Differential fluorescence nanoparticle tracking analysis for enumeration of the extracellular vesicle content in mixed particulate solutions.
Desgeorges A; Hollerweger J; Lassacher T; Rohde E; Helmbrecht C; Gimona M
Methods; 2020 May; 177():67-73. PubMed ID: 32081745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
